PROFILE OF LIFESTYLE-RELATED NON-COMMUNICABLE DISEASES IN ADULTS ATTENDING THE MEDICINE OPD OF A TERTIARY CARE HOSPITAL
Main Article Content
Keywords
Non-communicable diseases; Lifestyle; Hypertension; Diabetes; Dyslipidaemia; Metabolic syndrome; Tertiary care OPD
Abstract
Background: Non-communicable diseases (NCDs) driven by lifestyle-related risk factors constitute a major and growing public health burden in India.
Objectives: To determine the profile of lifestyle-related NCDs and associated risk factors among adults attending the Medicine OPD of a tertiary care hospital.
Methods: A cross-sectional observational study was conducted over 6 months in 100 adults aged ≥18 years attending the Medicine OPD. Sociodemographic data, lifestyle risk factors (tobacco, alcohol, physical inactivity, unhealthy diet, obesity), and clinical diagnoses were recorded using a structured proforma. Metabolic parameters were assessed biochemically. Data were analysed using descriptive statistics and Chi-square test.
Results: Hypertension was the most prevalent NCD (54%), followed by overweight/obesity (56%), dyslipidaemia (48%), and Type 2 diabetes mellitus (T2DM) (46%). Unhealthy diet (72%) and physical inactivity (64%) were the most prevalent lifestyle risk factors. Multiple NCDs coexisted in 38% of patients, and metabolic syndrome was present in 32%. Physical inactivity, unhealthy diet, and overweight were significantly associated with all three major NCDs (p<0.05).
Conclusion: Lifestyle-related NCDs are highly prevalent in OPD attendees of tertiary care. Unhealthy diet, physical inactivity, and obesity are the dominant modifiable risk factors, warranting targeted screening and lifestyle modification programmes.
References
2. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019. Lancet. 2020;396(10258):1204–22.
3. Patel V, Chatterji S, Chisholm D, Ebrahim S, Gopalakrishna G, Mathers C, et al. Chronic diseases and injuries in India. Lancet. 2011;377(9763):413–28.
4. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research–INdia DIABetes (ICMR–INDIAB) study. Diabetologia. 2011;54(12):3022–7.
5. Hirode G, Wong RJ. Trends in the prevalence of metabolic syndrome in the United States, 2011–2016. JAMA. 2020;323(24):2526–8. [Indian data cited from: Aggarwal R, Bhatt DL, Yusuf S. Prevalence of metabolic syndrome among adult population in India: systematic review and meta-analysis. PLoS One. 2020;15(10):e0240971.]
6. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356–9.
7. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127–248.
8. American Diabetes Association. Standards of medical care in diabetes — 2021. Diabetes Care. 2021;44(Suppl 1):S1–S232.
9. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.
10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Circulation. 2009;120(16):1640–5.
11. Garg N, Muduli SK, Kapoor A, Tewari S, Kumar S, Khanna R, et al. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses. Indian Heart J. 2017;69(4):458–63.
12. Pati MK, Swaroop N, Kar A, Agasha GN, Jayanna K, Liljestrand J, et al. Designing a comprehensive non-communicable diseases (NCDs) programme for hypertension and diabetes at primary level care in Bellary and Koppal districts of Karnataka, India: findings and implications. BMC Health Serv Res. 2019;19(1):244.
13. Ministry of Health and Family Welfare, Government of India. Global Adult Tobacco Survey India 2016–17. New Delhi: MoHFW; 2018.
14. Singh SP, Balhara YP. A review of Indian research on co-occurring disorders. Indian J Psychiatry. 2014;56(Suppl 2):S254–64.
15. World Health Organization. WHO STEPS Surveillance Manual: The WHO STEPwise Approach to Noncommunicable Disease Risk Factor Surveillance. Geneva: WHO; 2017.
16. Bhattacherjee S, Datta S, Ray K, Chakraborty M. Non-communicable disease risk factors among adult slum dwellers of Darjeeling town, West Bengal. J Family Med Prim Care. 2016;5(3):600–6.
17. Sharma S, Tandon VR, Mahajan A. Obesity: friend or foe for osteoporosis. J Med Nutr Nutraceut. 2014;3(1):3–9.
18. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–68.
19. Gupta R, Misra A, Vikram NK, Kondal D, Gupta SS, Agrawal A, et al. Younger age of escalation of cardiovascular risk factors in Asian Indian subjects. BMC Cardiovasc Disord. 2009;9:28.
20. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S9–30.
21. Jindal SK, Aggarwal AN, Gupta D, Agarwal R, Kumar R, Kaur T, et al. Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis. 2012;16(9):1270–7.

